Maureen Lynch, Wun-Ju Shieh, Joseph S. Bresee, Kathleen M. Tatti, Jon R. Gentsch, Tara Jones, Baoming Jiang, Erik Hummelman, Christopher M. Zimmerman, Sherif R. Zaki, and Roger I. Glass Intussusception After Administration of the Rhesus Tetravalent Rotavirus Vaccine (Rotashield): The Search for a Pathogenic Mechanism. Pediatrics, May 2006; 117: e827 – e832.
OBJECTIVES. The rhesus tetravalent rotavirus vaccine (RRV) was withdrawn from the routine program for childhood immunization in the United States because of the rare and unexpected occurrence of intussusception in the 2-week period after
administration of the first dose.
METHODS. To search for the pathogenesis of this association, we compared the pathology of surgical specimens from infants who had surgical reduction of their intussusceptions within 2 weeks of receiving the vaccine (case patients; n _ 8) with the pathology of specimens from children who had surgery _2 weeks after
immunization (n _ 6) or who had never been immunized (n _ 26). Tissue was examined for evidence of the vaccine strain of rotavirus by reverse transcriptasepolymerase chain reaction (RT-PCR), in situ hybridization, and immunohistochemical
staining.
RESULTS. RRV was identified by RT-PCR in tissue samples from 7 of the 8 case patients and in 2 of the 6 children who received the vaccine at a more distant time (29 and 58 days before surgery), but it was not identified in samples from any of the nonvaccinated children. No evidence of rotavirus tissue involvement was
detected in any of the children by in situ hybridization or immunohistochemical staining. Pathologic evidence (for example, inclusion bodies, smudge cells) of adenovirus infection was present in 35% of the 37 specimens examined by routine
staining and immunohistochemistry.
CONCLUSIONS. The fact that RRV was detected by RT-PCR but not by either of the other assays could be explained by RRV being present in the lumen of the gut but not in the tissues of appendix, ileum, or Peyer’s patches. The Peyer’s patches were not hyperplastic, and we could not establish the pathogenic mechanism for this association.
Atencion Primaria 
En teoria son las mismas, lo que estadisticamente lo hace más improbable, pero los sistemas abiertos como nuestra especie suele no guiarse por esos parametros. No encontre ningun articulo sobre problemas en la segunda dosis, los reportes de farmacovigilancia no discriminan en que dosis sucedio el cuadro de intuscepcion. En mi opinion esta vacuna no debiera darse nunca ya que en los estudios de fase III ya el numero de complicaciones era mayor al numero de complicaciones de una vacuna utilizada unos 8 años atras y que fue sacada del mercado. Notoriamente la complicacion de instuscepcion se daba tambien con aquella vacuna.
Hola consulte este articulo debido a que tengo una bebe de 4 meses de edad, que se le administro el rotarix y a las 3 semanas exactas de su aplicacion se desencadena cuadro de invaginacion intestinal que se caracterizo por llanto importante, distension abdominal, fibre evacuacion sanguinolenta, vomito en una ocasion por lo que me interesa conocer todas las reacciones adversas ante su segunda aplicacion